Label Image (Lbl500903485)
Valsartan And Hydrochlorothiazide
Product Images NDC 50090-3485
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-3485). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Valsahctz Figur1)
This is a graph showing the probability of achieving a systolic blood pressure of less than 140 mmHg at week 8. The x-axis represents different baseline systolic blood pressure readings from 140 to 180 mmHg. The y-axis shows the probability of achieving the target blood pressure. The graph compares the effectiveness of Valsartan and hydrochlorothiazide tablets (at a dose of 320/25 mg) to placebo tablets in achieving the target blood pressure. There is no other information available other than the graph.*
Figure 2-3-4 (Valsahctz Figure2 3 4)
The text describes the probability of achieving systolic and diastolic blood pressure goals with the combination of Valsartan and Hydrochlorothiazide tablets at different doses compared to a placebo. The graph figures show the probability of achieving a diastolic blood pressure of less than 90 mmHg or 80 mmHg or a systolic blood pressure of less than 130 mmHg after eight weeks of treatment with different combinations of the drugs.*
Structure (Valsahctz Hctz)
Structure (Valsahctz Valsa)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
